Lechien J.R. Chiesa-Estomba C.M. De Siati D.R. et al.

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.

Eur Arch Otorhinolaryngol. 277: 2251-2261Chou S.H.Y. Beghi E. Helbok R. et al.

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.

JAMA Netw Open. 4: e2112131

Neurologic manifestations of severe acute respiratory syndrome coronavirus 2 infection.

Continuum (Minneap Minn). 27: 1051-1065

The gendered dimensions of COVID-19.

Lancet. 395: 1168

The sex, gender, and COVID-19 project. 2021.

() ()Trifan G. Goldenberg F.D. Caprio F.Z. et al.

Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex.

J Stroke Cerebrovasc Dis. 29: 105314Vahidy F.S. Meeks J. Pan A. et al.

Abstract 13: Sex differences in mortality among patients with COVID-19 related stroke.

Stroke. 52: A13World Health Organization

A clinical case definition of post-COVID-19 condition by a Delphi consensus.

() ()Centers for Disease Control and Prevention

Long COVID or Post-COVID Conditions.

() ()Sylvester S.V. Rusu R. Chan B. et al.

Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review.

Curr Med Res Opin. : 1-9https://doi.org/10.1080/03007995.2022.2081454Jensen A. Castro A.W. Ferretti M.T. et al.

Sex and gender differences in the neurological and neuropsychiatric symptoms of long covid: a narrative review.

Ital J Gender-specific Med. 8: 18-28Takahashi T. Ellingson M.K. Wong P. et al.

Sex differences in immune response that underlie COVID-19 disease outcomes.

Nature. 588: 315-320

Hypothesis: sex-related differences in ACE2 activity may contribute to higher mortality in men versus women with COVID-19.

J Cardiovasc Pharmacol Ther. 26: 114-118Dalpiaz E.P.L.M. Lamas A.Z. Caliman I.F. et al.

Correction: sex hormones promote opposite effects on ACE and ACE2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats.

PLoS One. 10: e0133225Gupte M. Thatcher S.E. Boustany-Kari C.M. et al.

Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 Mice.

Arterioscler Thromb Vasc Biol. 32: 1392-1399World Health Organization

HIV.

() ()

Neurologic complications of human immunodeficiency virus.

Continuum (Minneap Minn). 27: 963-991Sacktor N. Skolasky R.L. Seaberg E. et al.

Prevalence of HIV-associated neurocognitive disorders in the multicenter AIDS cohort study.

Neurology. 86: 334-340Rubin L.H. Neigh G.N. Sundermann E.E. et al.

Sex differences in neurocognitive function in adults with HIV: patterns, predictors, and mechanisms.

Curr Psychiatry Rep. 21: 94Sundermann E.E. Heaton R.K. Pasipanodya E. et al.

Sex differences in HIV-associated cognitive impairment.

AIDS. 32: 2719-2726Maki P.M. Rubin L.H. Springer G. et al.

Differences in cognitive function between women and men with HIV.

J Acquir Immune Defic Syndr. 79: 101-107Rubin L.H. Sundermann E.E. Dastgheyb R. et al.

Sex differences in the patterns and predictors of cognitive function in HIV.

Front Neurol. 11: 551921Maki P.M. Rubin L.H. Valcour V. et al.

Cognitive function in women with HIV: findings from the Women’s Interagency HIV Study.

Neurology. 84: 231-240Mathad J.S. Gupte N. Balagopal A. et al.

Sex-related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation.

J Acquir Immune Defic Syndr. 73: 123-129Edwards N.J. Grill M.F. Choi A. et al.

Frequency and risk factors for cerebral arterial disease in a HIV/AIDS neuroimaging cohort.

Cerebrovasc Dis. 41: 170-176Chow F.C. Regan S. Feske S. et al.

Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system.

J Acquir Immune Defic Syndr. 60: 351-358

Congenital infections of the nervous system.

Continuum (Minneap Minn). 27: 1105-1126Bollani L. Auriti C. Achille C. et al.

Congenital toxoplasmosis: the state of the art.

Front Pediatr. 10: 894573World Health Organization

WHO guidelines for the treatment of treponema pallidum (syphilis).

() ()Arnold S.R. Ford-Jones E.L.

Congenital syphilis: a guide to diagnosis and management.

Paediatr Child Health. 5: 463-469Rubella Lancet. 399: 1336-1346Lazzarotto T. Guerra B. Gabrielli L. et al.

Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy.

Clin Microbiol Infect. 17: 1285-1293Wilmshurst J.M. Hammon C.K. Donald K. et al.

NeuroAIDS in children.

Handb Clin Neurol. 152: 99-116Rudnick C.M. Hoekzema G.S.

Neonatal herpes simplex virus infection.

Am Fam Physician. 65: 1138-1142Freitas D.A. Souza-Santos R. Carvalho L.M.A. et al.

Congenital Zika syndrome: A systematic review.

PLoS One. 15: e0242367Kleber de Oliveira W. Cortez-Escalante J. De Oliveira W.T.G.H. et al.

Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015.

MMWR Morb Mortal Wkly Rep. 65: 242-247Cuevas E.L. Tong V.T. Rozo N. et al.

Preliminary report of microcephaly potentially associated with Zika virus infection during pregnancy - Colombia, January-November 2016.

MMWR Morb Mortal Wkly Rep. 65: 1409-1413Reynolds M.R. Jones A.M. Petersen E.E. et al.

Vital signs: update on Zika virus-associated birth defects and evaluation of all U.S. Infants with congenital Zika virus exposure—U.S. Zika Pregnancy Registry, 2016.

MMWR Morb Mortal Wkly Rep. 66: 366-373

Paraneoplastic syndromes: When to suspect, how to confirm, and how to manage.

J Neurol Neurosurg Psychiatry. 75: ii43-ii50Zaborowski M.P. Spaczynski M. Nowak-Markwitz E. et al.

Paraneoplastic neurological syndromes associated with ovarian tumors.

J Cancer Res Clin Oncol. 141: 99-108Peterson K. Rosenblum M.K. Kotanides H. et al.

Paraneoplastic cerebellar degeneration: I.A clinical analysis of 55 anti–Yo antibody–positive patients.

Neurology. 42: 1931-1937Rojas I. Graus F. Keime-Guibert F. et al.

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

Neurology. 55: 713-715

Paraneoplastic neurological complications of breast cancer.

Exp Hematol Oncol. 5: 29Keime-Guibert F. Graus F. Fleury A. et al.

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

J Neurol Neurosurg Psychiatry. 68: 479-482Dalmau J. Tüzün E. Wu H.Y. et al.

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Ann Neurol. 61: 25-36Cho E.H. Byun J.M. Park H.Y. et al.

The first case of Anti-N-methyl-D-aspartate receptor encephalitis (Anti-NMDAR encephalitis) associated with ovarian mucinous cystadenoma: A case report.

Taiwan J Obstet Gynecol. 58: 557-559Schmitt S.E. Pargeon K. Frechette E.S. et al.

Extreme delta brush; A unique EEG pattern in adults with anti-NMDA receptor encephalitis.

Neurology. 79: 1094-1100Whitehead K. Pressler R. Fabrizi L.

Characteristics and clinical significance of delta brushes in the EEG of premature infants.

Clin Neurophysiol Pract. 2: 12-18Dalmau J. Gleichman A.J. Hughes E.G. et al.

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Lancet Neurol. 7: 1091-1098Dalmau J. Lancaster E. Martinez-Hernandez E. et al.

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Lancet Neurol. 10: 63-74

Peripheral neuropathy in ovarian cancer.

in: Farghaly S. Ovarian cancer - clinical and therapeutic Perspectives. InTech, : 109-128Mcpherson K. Steel C.M. Dixon J.M.

ABC of breast disease. Breast cancer - epidemiology, risk factors, and genetics.

BMJ. 312: 624-628

Stiff-person syndrome.

Neurologist. 10: 131-137Klaas J.P. Ahlskog J.E. Pittock S.J. et al.

Adult-onset opsoclonus-myoclonus syndrome.

Arch Neurol. 69: 1598-1607Peterson K. Forsyth P.A. Posner J.B.

Paraneoplastic sensorimotor neuropathy associated with breast cancer.

J Neurooncol. 21: 159-170Sandroni C. Cronberg T. Sekhon M.

Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis.

Intensive Care Med. 47: 1393-1414Nolan J.P. Morley P.T. Hoek T.L.V. et al.

Therapeutic hypothermia after cardiac arrest: An advisory statement by the Advanced Life Support Task Force of the International Liaison Committee on Resuscitation.

Circulation. 57: 231-235Nielsen N. Wetterslev J. Cronberg T. et al.

Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest.

N Engl J Med. 369: 2197-2206Dankiewicz J. Cronberg T. Lilja G. et al.

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest.

N Engl J Med. 384: 2283-2294Johnson M.A. Haukoos J.S. Larabee T.M. et al.

Females of childbearing age have a survival benefit after out-of-hospital cardiac arrest.

Resuscitation. 84: 639-644Mirza M.A. Ritzel R. Xu Y. et al.

Sexually dimorphic outcomes and inflammatory responses in hypoxic-ischemic encephalopathy.

J Neuroinflammation. 12: 32Murden S. Borbélyová V. Laštůvka Z. et al.

Gender differences involved in the pathophysiology of the perinatal hypoxic-ischemic damage.

Physiol Res. 68: S207-S217Mody P. Pandey A. Slutsky A.S. et al.

Gender-based differences in outcomes among resuscitated patients with out-of-hospital cardiac arrest.

Circulation. 143: 641-649Nehme Z. Andrew E. Bernard S. et al.

Sex differences in the quality-of-life and functional outcome of cardiac arrest survivors.

Resuscitation. 137: 21-28Lei H. Hu J. Liu L. et al.

Sex differences in survival after out-of-hospital cardiac arrest: a meta-analysis.

Crit Care. 24: 613Kotini-Shah P. Del Rios M. Khosla S. et al.

Sex differences in outcomes for out-of-hospital cardiac arrest in the United States.

Resuscitation. 163: 6-13Noppens R.R. Kofler J. Grafe M.R. et al.

Estradiol after cardiac arrest and cardiopulmonary resuscitation is neuroprotective and mediated through estrogen receptor-β.

J Cereb Blood Flow Metab. 29: 277-286Ikeda M. Swide T. Vayl A. et al.

Estrogen administered after cardiac arrest and cardiopulmonary resuscitation ameliorates acute kidney injury in a sex- and age-specific manner.

Crit Care. 19: 332